How CFOs Plan R&D Funding for HMRC and Innovate UK Timelines

R&D delivery runs on calendars and cash dates. Claims, milestone dates and supplier lead times rarely move, so the plan works only when R&D Funding lines up with real costs. SPRK Capital focuses on non‑dilutive funding that follows your project cadence. We are backed by a £20 million facility from British Business Investments, which gives dependable capacity as programmes scale.

What sits under “R&D funding” in the UK?

R&D funding combines grants, tax relief and innovation‑aligned lending.

• Grants (for example, Innovate UK) support specific projects and pay in arrears against eligible, evidenced costs. View our hub on R&D grants.
• R&D tax relief reduces corporation tax or produces a payable credit after year‑end when claims are filed. Read on R&D Tax Credit Loans for bridging options to expected receipts.
• Innovation‑aligned lending provides working capital around pilots, certifications and early go‑to‑market. Check our Innovation Term Loans page for more information.

How do Innovate UK grants pay?

Most grants pay in arrears against costs you have incurred and paid, once monitoring and evidence checks complete.

Start delivery only after the project is set up and the official go‑live is confirmed. Keep invoices, proof of payment and timesheets aligned to the eligible cost categories in your offer letter annexes. Many competitions use quarterly claims; some align payment to milestone approvals. In both cases cash lands after evidence review, which means payroll and supplier dates can arrive before receipts.

What does your Monitoring Officer check before a claim pays?

Innovate UK grants are paid in arrears once you incur, invoice and pay eligible costs, then evidence them in the portal. Before a claim reaches Innovate UK, your Monitoring Service Provider (MSP) reviews the pack against the offer letter and annexes. Expect to provide invoices and proof of payment, timesheets mapped to eligible categories, and short progress notes that show you have met the period’s deliverables. Claims can be queried or held until evidence is complete, so keep the trail clean and dated to reduce delays. This is why payroll, deposits and booked lab/certification time can land before cash does and why CFOs plan R&D funding to your claim windows or milestone dates, not just the project plan.

Where do timing gaps hurt delivery?

Gaps appear when payroll, supplier pre‑payments and booked lab or certification time arrive before a grant or credit is received.

Pressure points include payroll between sprints, minimum order quantities with deposits, laboratory bookings, certification runs and scheduled pilot trials with partners. If a date slips, acceptance can move into the next window and delay revenue recognition. When scope or timing must change, raise a project change request early so claims stay aligned to the approved plan.

What does a 12–18 month R&D Funding calendar look like?

Map funding to the same calendar you use for delivery and acceptance.

• Months 0–3: Finalise set‑up and go‑live. Lock supplier deposits and facility bookings. Build the evidence trail from day one.
• Months 3–6: First claim window opens. Prepare invoices, proof of payment and timesheets. If dates are fixed and cash is tight, consider a Grant Advance Funding facility aligned to the relevant claim window or milestone date.
• Months 6–12: Year‑end and R&D claim preparation. Profile eligible activities and costs with your advisers. If delivery depends on the expected credit, explore R&D Tax Credit Loans to bridge to HMRC receipt.
• Months 9–18: Pilots, certifications and early go‑to‑market. Use Innovation Term Loans to fund working capital with a clear plan and reporting cadence.

What documents keep claims moving on time?

Keep a short, current pack that matches how schemes review evidence.

• Award letter with annexes and the latest milestone schedule.
• Project plan or Gantt with dated tasks, owners and milestone dates.
• 13‑week cash‑flow and recent management accounts for cash timing.
• Invoices and proof of payment; timesheets mapped to eligible categories; short progress notes and outputs where required.

This keeps R&D funding predictable and claims on time.

How do boards and investors view R&D Funding in 2025?

They want evidence discipline, credible schedules and transparent funding lines that match the plan.

Boards expect claims to be supported by clean records, clear ownership of tasks and consistent cash‑flow forecasting. Investors look for non‑dilutive options that extend runway ahead of value inflection points. SPRK’s capacity is strengthened by our partnership with British Business Investments, which supports eligible drawdowns as programmes scale.

When should a CFO speak to a funding partner?

Speak to us before you lock in payroll, place supplier orders or book lab or certification time. We will check your dates with you and confirm if funding can match them. You do not need a full pack to start; tell us the next key date and the costs that fall before it.

If it fits, we will send a clear plan that sets out the amount, timing and costs in writing so you can brief the board with confidence. When you want R&D Funding that lines up with your project calendar, contact us.